A sensitive fluorometric enzyme-linked immunosorbent assay that measures vascular endothelial growth factor165 in human plasma

Journal of Immunological Methods

Volumn 219, Issue 1-2, 1998, Pages 45-55

  Rodriguez, Carlos R ^a   Fei, David T ^a   Keyt, Bruce ^a   Baly, Deborah L ^a  

^a GENENTECH INC   (United States)

Author keywords

ELISA; Human plasma; Immunoassay; VEGF

Indexed keywords

PLASMIN; VASCULOTROPIN;

ACCURACY; ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROMETRY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANTIBODIES; ANTIBODIES, MONOCLONAL; BIOTINYLATION; CROSS REACTIONS; DIMERIZATION; EDETIC ACID; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN; HUMANS; LYMPHOKINES; MALE; NEOPLASMS; PROTEIN ISOFORMS; RECOMBINANT PROTEINS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032191768     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(98)00131-8     Document Type: Article

References (39)

1. Anthony F.W., Evans P.W., Wheeler T., Wood P.J. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann. Clin. Biochem. 34:1997;276.
2. Baccala A.A., Zhong H., Clift S.M., Nelson W.G., Marshall F.F., Passe T.J., Gambill N.B., Simons J.W. Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer. Urology. 51:1998;327.
3. Baker P.N., Krasnow J., Roberts J.M., Yeo K.T. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet. Gynecol. 86:1995;815.
4. Charnock-Jones D.S., Sharkey A.M., Day K., Smith S.K. Identification and characterisation of soluble variants of vascular endothelial growth factor (VEGF) receptors in the human placenta. Placenta. 16:1995;A11.
5. Chiang M.K., Flanagan J.G. Interactions between the Flk-1 receptor, vascular endothelial growth factor, and cell surface proteoglycan identified with a soluble receptor reagent. Growth Factors. 12:1995;1.
6. de Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., Williams L.T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 255:1992;989.
7. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161:1989;851.
8. Ferrara N., Houck K., Jakeman L., Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13:1992;18.
9. Ferrari G., Scagliotti G.V. Serum and urinary vascular endothelial growth factor levels in non-small cell lung cancer patients. Eur. J. Cancer. 32A:1996;2368.
10. Fujisaki K., Mitsuyama K., Toyonaga A., Matsuo K., Tanikawa K. Circulating vascular endothelial growth factor in patients with colorectal cancer. Am. J. Gastroenterol. 93:1998;249.
11. Gabrilovich D.I., Chen H.L., Girgis K.R., Cunningham H.T., Meny G.M., Nadaf S., Kavanaugh D., Carbone D.P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 2:1996;1096.
12. Gasparini G., Toi M., Gion M., Verderio P., Dittadi R., Hanatani M., Matsubara I., Vinante O., Bonoldi E., Boracchi P., Gatti C., Suzuki H., Tominaga T. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J. Natl. Cancer Inst. 89:1997;139.
13. Gospodarowicz D., Abraham J.A., Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7311.
14. Hanatani M., Tanaka Y., Kondo S., Ohmori I., Suzuki H. Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Biosci. Biotechnol. Biochem. 59:1995;1958.
15. Houck K.A., Ferrara N., Winer J., Cachianes G., Li B., Leung D.W. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5:1991;1806.
16. Houck K.A., Leung D.W., Rowland A.M., Winer J., Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267:1992;26031.
17. Kendall R.L., Wang G., Thomas K.A. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun. 226:1996;324.
18. Keyt B.A., Berleau L.T., Nguyen H.V., Chen H., Heinsohn H., Vandlen R., Ferrara N. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J. Biol. Chem. 271:1996;7788.
19. Keyt B.A., Nguyen H.V., Berleau L.T., Duarte C.M., Park J., Chen H., Ferrara N. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem. 271:1996;5638.
20. Kim K.J., Li B., Houck K., Winer J., Ferrara N. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors. 7:1992;53.
21. Kohn E.C. Angiogenesis in ovarian carcinoma - a formidable biomarker. Cancer. 80:1997;2219.
22. Kondo S., Asano M., Matsuo K., Ohmori I., Suzuki H. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim. Biophys. Acta. 1221:1994;211.
23. Leith J.T., Michelson S. Secretion rates and levels of vascular endothelial growth factor in clone A or HCT-8 human colon tumour cells as a function of oxygen concentration. Cell Prolif. 28:1995;415.
24. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306.
25. Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N.P., Risau W., Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 72:1993;835.
26. Neufeld G., Tessler S., Gitay-Goren H., Cohen T., Levi B.Z. Vascular endothelial growth factor and its receptors. Prog. Growth Factor Res. 5:1994;89.
27. Paavonen K., Horelli-Kuitunen N., Chilov D., Kukk E., Pennanen S., Kallioniemi O.P., Pajusola K., Olofsson B., Eriksson U., Joukov V., Palotie A., Alitalo K. Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. Circulation. 93:1996;1079.
28. Park J.E., Keller G.A., Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell. 4:1993;1317.
29. Plouet J., Schilling J., Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J. 8:1989;3801.
30. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:1983;983.
31. Shifren J.L., Tseng J.F., Zaloudek C.J., Ryan I.P., Meng Y.G., Ferrara N., Jaffe R.B., Taylor R.N. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab. 81:1996;3112.
32. Soker et al., 1993.
33. Takano S., Yoshii Y., Kondo S., Suzuki H., Maruno T., Shirai S., Nose T. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 56:1996;2185.
34. Terman B.I., Dougher-Vermazen M., Carrion M.E., Dimitrov D., Armellino D.C., Gospodarowicz D., Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187:1992;1579.
35. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., Abraham J.A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:1991;11947.
36. Toi M., Kondo S., Suzuki H., Yamamoto Y., Inada K., Imazawa T., Taniguchi T., Tominaga T. Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer. 77:1996;1101.
37. Yang R., Bunting S., Ko A., Keyt B.A., Modi N.B., Zioncheck T.F., Ferrara N., Hongkui J. Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection. J. Pharm. Exp. Ther. 284:1998;103.
38. Yeo K.T., Sioussat T.M., Faix J.D., Senger D.R., Yeo T.K. Development of time-resolved immunofluorometric assay of vascular permeability factor. Clin. Chem. 38:1992;71.
39. Yeo K.T., Wang H.H., Nagy J.A. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res. 53:1993;2912.